Hana Studenovska

Dr. Hana Studenovska

Institute of Macromolecular Chemistry CAS, Heyrovského nám. 2, 162 06 Prague 6, Czech Republic
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2003 in Colloids and Surfaces A: Physicochemical and Engineering Aspects
Verified
Journal Article
Closed access
Marian LehockyMarian Lehocky
Marian Lehocky
HSHana Studenovska
Hana Studenovska
BLBarbora Lapčíková
Barbora Lapčíková
Ana Barros timmonsAna Barros timmons
Ana Barros timmons
Tito TrindadeTito Trindade
Tito Trindade
LLLubomir Lapcik
Lubomir Lapcik

28 February 2003 in Colloid and Polymer Science
Verified
Journal Article
Closed access
PDF file
HSHana Studenovska
Hana Studenovska
LLLubomir Lapcik
Lubomir Lapcik
VBVilma Bursikova
Vilma Bursikova
JZJosef Zemek
Josef Zemek
Ana Barros timmonsAna Barros timmons
Ana Barros timmons

23 December 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MBMariana Bravo-Hernandez
Mariana Bravo-Hernandez
TTTakahiro Tadokoro
Takahiro Tadokoro
MNMichael R. Navarro
Michael R. Navarro
OPOleksandr Platoshyn
Oleksandr Platoshyn
YKYoshiomi Kobayashi
Yoshiomi Kobayashi
MMMartin Marsala
Martin Marsala

10 July 2007 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
HSHana Studenovska
Hana Studenovska
Miroslav SloufMiroslav Slouf
Miroslav Slouf
FRFrantišek Rypáček
František Rypáček

1 August 2015 in Biomedical Materials
Verified
Journal Article
Closed access
ŠPŠtěpán Popelka
Štěpán Popelka
HSHana Studenovska
Hana Studenovska
LALucie Abelová
Lucie Abelová
TATaras Ardan
Taras Ardan
PSPavel Studený
Pavel Studený
FRFrantišek Rypáček
František Rypáček
We report on the design and fabrication of a frame-supported nanofibrous membrane for the transplantation of retinal pigment epithelial (RPE) cells, which is a promising therapeutic option for the treatment of degenerative retinal disorders. The membranous cell carrier prepared from 640 nm-thick poly(DL-lactide) fibres uniquely combines high porosity, large pore size and low thickness, to maximize the nutrient supply to the transplanted cells in the subretinal space and thus to enhance the therapeutic effect of the transplantation. The carrier was prepared by electrospinning, which made it easy to embed a 95 μm-thick circular supporting frame 2 mm in diameter. Implantations into enucleated porcine eyes showed that the frame enabled the ultrathin membrane to be handled without irreversible folding, and allowed the membrane to regain its flat shape when inserted into the subretinal space. We further demonstrated that the minimum membrane thickness compatible with the surgical procedure and instrumentation employed here was as low as 4 μm. Primary porcine RPE cells cultivated on the membranes formed a confluent monolayer, expressed RPE-specific differentiation markers and showed transepithelial resistance close to that of the native RPE. Most importantly, the majority of the RPE cells transplanted into the subretinal space remained viable. The ultrathin, highly porous, and surgically convenient cell carrier presented here has the potential to improve the integration and the functionality of transplanted RPE cells.

23 January 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
SGSantosh Gupta
Santosh Gupta
LLLyubomyr Lytvynchuk
Lyubomyr Lytvynchuk
TATaras Ardan
Taras Ardan
HSHana Studenovska
Hana Studenovska
GMGeorgina Faura Muñoz
Georgina Faura Muñoz
GPGoran Petrovski
Goran Petrovski
The retinal pigment epithelium (RPE) forms an important cellular monolayer, which contributes to the normal physiology of the eye. Damage to the RPE leads to the development of degenerative diseases, such as age-related macular degeneration (AMD). Apart from acting as a physical barrier between the retina and choroidal blood vessels, the RPE is crucial in maintaining photoreceptor (PR) and visual functions. Current clinical intervention to treat early stages of AMD includes stem cell-derived RPE transplantation, which is still in its early stages of evolution. Therefore, it becomes essential to derive RPEs which are functional and exhibit features as observed in native human RPE cells. The conventional strategy is to use the knowledge obtained from developmental studies using various animal models and stem cell-based exploratory studies to understand RPE biogenies and developmental trajectory. This article emphasises such studies and aims to present a comprehensive understanding of the basic biology, including the genetics and molecular pathways of RPE development. It encompasses basic developmental biology and stem cell-based developmental studies to uncover RPE differentiation. Knowledge of the in utero developmental cues provides an inclusive methodology required for deriving RPEs using stem cells.